Table 7.
Post hoc analysis of interactions between patients with polysubstance use disorder comorbid with a depressive episode (PUD MDD)/control and DRD4 exon 3 (DRD4 Ex3) and the NEO FFI Extraversion/Conscientiousness Scale.
| DRD4 Ex3 and NEO FFI Extraversion Scale | ||||||
|
{1}
M = 4.57 |
{2}
M = 5.71 |
{3}
M = 9.00 |
{4}
M = 6.28 |
{5}
M = 6.37 |
{6}
M = 6.73 |
|
| PUD MDD DRD4 Ex3 s/l {1} | 0.0145 * | 0.0033 * | 0.0001 * | <0.0000 * | 0.0001 * | |
| PUD MDD DRD4 Ex3 s/s {2} | 0.0261 * | 0.0905 | 0.0290 * | 0.0339 * | ||
| PUD MDD DRD4 Ex3 l/l {3} | 0.0633 | 0.0720 | 0.1319 | |||
| control DRD4 Ex3 s/l {4} | 0.7060 | 0.3143 | ||||
| control DRD4 Ex3 s/s {5} | 0.4060 | |||||
| control DRD4 Ex3 l/l {6} | ||||||
| DRD4 Ex3 and NEO FFI Conscientiousness Scale | ||||||
|
{1}
M = 4.39 |
{2}
M = 5.14 |
{3}
M = 9.50 |
{4}
M = 6.13 |
{5}
M = 6.04 |
{6}
M = 6.15 |
|
| PUD MDD DRD4 Ex3 s/l {1} | 0.1210 | 0.0011 * | 0.0002 * | 0.0002 * | 0.0025 * | |
| PUD MDD DRD4 Ex3 s/s {2} | 0.0045 * | 0.0041 * | 0.0042 * | 0.0419 * | ||
| PUD MDD DRD4 Ex3 l/l {3} | 0.0271 * | 0.0226 * | 0.0325 * | |||
| control DRD4 Ex3 s/l {4} | 0.7281 | 0.9640 | ||||
| control DRD4 Ex3 s/s {5} | 0.7980 | |||||
| control DRD4 Ex3 l/l {6} | ||||||
* Statistically significant differences; M, mean.